Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK
Clinical trial NCT02826811 · UNKNOWN
Trial details
- NCT number
- NCT02826811
- Sponsor
- University Hospital, Strasbourg, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-05-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.